Should We Overhaul the Drug Development and Pricing System?
Setup
The high cost of pharmaceuticals gets a lot of public attention, but that is only the endpoint of a long pipeline that moves drugs from the laboratory, to clinical testing, to approval, and into the marketplace. In the era of precision medicine, we urgently need a system that supports the development of innovative therapies at every step — but just as urgently, we need strategies that allow consumers to gain access to them at reasonable prices. Eminent health economists look into the heart of the drug discovery framework and answer the question patients care most about: Can the system work better so we can pay for the therapies we need?
Speakers
-
Len NicholsProfessor of Health Policy and Director, Center for Health Policy Rese... -
Margot Sanger-KatzHealth Care Correspondent, The New York Times -
Stacie DusetzinaProfessor at Vanderbilt University School of Medicine -
Craig GarthwaiteProfessor at Northwestern University’s Kellogg School of Management
- 2019 Health
Explore More
Education
From blockchain to back to school and virus-hunting to bridging divides, speakers at the 2021 Aspen Ideas Festival addressed issues in a new kind of world—one touched, and cha...
When children see themselves and their communities mirrored in school curriculum, they learn better. But traditional curriculum situates people of the African Diaspora in a mi...
With many students returning to school from the comfort of their living rooms, educators are using this unique period to address long-standing problems of equity.
The reality of educating children during a pandemic can be overwhelming. Learn how educators and policymakers are working to ensure every child is digitally connected.
Tech tools that can keep students engaged and help guard against learning loss are suddenly front and center.
Paying for college is becoming more difficult. So is justifying the full-freight cost of some private institutions.
